<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:6b022a16-48ce-4bfd-aba5-c1ded3f6845f,g:c6658699-6f52-4d39-9701-36967017fb12-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_431be7ee-5249-45dd-8f9f-3b1f59b4c476_negatedLabel_en" xlink:label="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en">Repayments of non-current borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:to="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests_2c7dbc4a-bdb2-4c73-b0fe-f3f25630bbdb_negatedLabel_en" xlink:label="lab_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en">Dividends recognised as distributions to non-controlling interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" xlink:to="lab_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_redcarepharmacynv_SellingAndDistributionExpense_label_en" xlink:label="lab_redcarepharmacynv_SellingAndDistributionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en">Selling and distribution expense</link:label>
    <link:label id="lab_redcarepharmacynv_SellingAndDistributionExpense_documentation_en" xlink:label="lab_redcarepharmacynv_SellingAndDistributionExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en">profit loss from operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_redcarepharmacynv_SellingAndDistributionExpense" xlink:href="redcarepharmacynv-2024-12-31.xsd#redcarepharmacynv_SellingAndDistributionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_redcarepharmacynv_SellingAndDistributionExpense" xlink:to="lab_redcarepharmacynv_SellingAndDistributionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_redcarepharmacynv_ReservesaccumulatedLosses_07939d14-f862-4ca9-b73c-883733cc403a_negatedLabel_en" xlink:label="lab_redcarepharmacynv_ReservesaccumulatedLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en">Reserves/accumulated losses</link:label>
    <link:label id="lab_redcarepharmacynv_ReservesaccumulatedLosses_label_en" xlink:label="lab_redcarepharmacynv_ReservesaccumulatedLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en">Reserves/accumulated losses</link:label>
    <link:label id="lab_redcarepharmacynv_ReservesaccumulatedLosses_documentation_en" xlink:label="lab_redcarepharmacynv_ReservesaccumulatedLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en">Reserves/accumulated losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_redcarepharmacynv_ReservesaccumulatedLosses" xlink:href="redcarepharmacynv-2024-12-31.xsd#redcarepharmacynv_ReservesaccumulatedLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_redcarepharmacynv_ReservesaccumulatedLosses" xlink:to="lab_redcarepharmacynv_ReservesaccumulatedLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_redcarepharmacynv_InvestmentIndisposalFromEscrowAccounts_label_en" xlink:label="lab_redcarepharmacynv_InvestmentIndisposalFromEscrowAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en">Investment in/disposal from escrow accounts</link:label>
    <link:label id="lab_redcarepharmacynv_InvestmentIndisposalFromEscrowAccounts_documentation_en" xlink:label="lab_redcarepharmacynv_InvestmentIndisposalFromEscrowAccounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en">Investment in/disposal from escrow accounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_redcarepharmacynv_InvestmentIndisposalFromEscrowAccounts" xlink:href="redcarepharmacynv-2024-12-31.xsd#redcarepharmacynv_InvestmentIndisposalFromEscrowAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_redcarepharmacynv_InvestmentIndisposalFromEscrowAccounts" xlink:to="lab_redcarepharmacynv_InvestmentIndisposalFromEscrowAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_0db42a91-9b63-4176-a5ea-0e9bf8d36568_totalLabel_en" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en">Cash flows from (used in) operations before changes in working capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInWorkingCapital_92cd8f59-4acb-42c3-b31f-85fe90334759_negatedTotalLabel_en" xlink:label="lab_ifrs-full_IncreaseDecreaseInWorkingCapital" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en">Increase (decrease) in working capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInWorkingCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInWorkingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital" xlink:to="lab_ifrs-full_IncreaseDecreaseInWorkingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_redcarepharmacynv_InvestmentInOtherFinancialAssets_label_en" xlink:label="lab_redcarepharmacynv_InvestmentInOtherFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en">Investment in other financial assets</link:label>
    <link:label id="lab_redcarepharmacynv_InvestmentInOtherFinancialAssets_documentation_en" xlink:label="lab_redcarepharmacynv_InvestmentInOtherFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en">Investment in other financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_redcarepharmacynv_InvestmentInOtherFinancialAssets" xlink:href="redcarepharmacynv-2024-12-31.xsd#redcarepharmacynv_InvestmentInOtherFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_redcarepharmacynv_InvestmentInOtherFinancialAssets" xlink:to="lab_redcarepharmacynv_InvestmentInOtherFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_redcarepharmacynv_AcquisitionOfSubsidiaryConsiderationInKind_label_en" xlink:label="lab_redcarepharmacynv_AcquisitionOfSubsidiaryConsiderationInKind" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en">Acquisition of subsidiary consideration in kind</link:label>
    <link:label id="lab_redcarepharmacynv_AcquisitionOfSubsidiaryConsiderationInKind_documentation_en" xlink:label="lab_redcarepharmacynv_AcquisitionOfSubsidiaryConsiderationInKind" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en">Acquisition of subsidiary consideration in kind</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_redcarepharmacynv_AcquisitionOfSubsidiaryConsiderationInKind" xlink:href="redcarepharmacynv-2024-12-31.xsd#redcarepharmacynv_AcquisitionOfSubsidiaryConsiderationInKind"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_redcarepharmacynv_AcquisitionOfSubsidiaryConsiderationInKind" xlink:to="lab_redcarepharmacynv_AcquisitionOfSubsidiaryConsiderationInKind" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_5f174c46-1be9-4fab-995f-6b474408cefc_totalLabel_en" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en">Cash flows from (used in) operating activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_redcarepharmacynv_CapitalIncreaseRelatedToBusinessCombinations_label_en" xlink:label="lab_redcarepharmacynv_CapitalIncreaseRelatedToBusinessCombinations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en">Capital increase related to business combinations</link:label>
    <link:label id="lab_redcarepharmacynv_CapitalIncreaseRelatedToBusinessCombinations_documentation_en" xlink:label="lab_redcarepharmacynv_CapitalIncreaseRelatedToBusinessCombinations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en">Capital increase related to business combinations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_redcarepharmacynv_CapitalIncreaseRelatedToBusinessCombinations" xlink:href="redcarepharmacynv-2024-12-31.xsd#redcarepharmacynv_CapitalIncreaseRelatedToBusinessCombinations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_redcarepharmacynv_CapitalIncreaseRelatedToBusinessCombinations" xlink:to="lab_redcarepharmacynv_CapitalIncreaseRelatedToBusinessCombinations" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_5e233ae4-7de8-4370-90c9-a827f50d23bc_totalLabel_en" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en">Cash flows from (used in) financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GrossProfit_16445fd6-8074-4be8-82a8-5dc341953f7d_totalLabel_en" xlink:label="lab_ifrs-full_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en">Gross profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit" xlink:to="lab_ifrs-full_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_redcarepharmacynv_IncreaseDecreaseInOtherNetCurrentAsset_label_en" xlink:label="lab_redcarepharmacynv_IncreaseDecreaseInOtherNetCurrentAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en">Increase/Decrease in other net current asset</link:label>
    <link:label id="lab_redcarepharmacynv_IncreaseDecreaseInOtherNetCurrentAsset_documentation_en" xlink:label="lab_redcarepharmacynv_IncreaseDecreaseInOtherNetCurrentAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en">Increase/Decrease in other net current asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_redcarepharmacynv_IncreaseDecreaseInOtherNetCurrentAsset" xlink:href="redcarepharmacynv-2024-12-31.xsd#redcarepharmacynv_IncreaseDecreaseInOtherNetCurrentAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_redcarepharmacynv_IncreaseDecreaseInOtherNetCurrentAsset" xlink:to="lab_redcarepharmacynv_IncreaseDecreaseInOtherNetCurrentAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities_45a3c328-1776-4d3a-948c-c8c91f05ec66_negatedLabel_en" xlink:label="lab_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en">Dividends paid to non-controlling interests, classified as financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_93b07928-cd5d-4af3-aca5-84826887ba00_totalLabel_en" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en">Cash Flows from/used in investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_redcarepharmacynv_AcquisitionOfSubsidiaryWithNCI_label_en" xlink:label="lab_redcarepharmacynv_AcquisitionOfSubsidiaryWithNCI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en">Acquisition of subsidiary with NCI</link:label>
    <link:label id="lab_redcarepharmacynv_AcquisitionOfSubsidiaryWithNCI_documentation_en" xlink:label="lab_redcarepharmacynv_AcquisitionOfSubsidiaryWithNCI" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en">Acquisition of subsidiary with NCI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_redcarepharmacynv_AcquisitionOfSubsidiaryWithNCI" xlink:href="redcarepharmacynv-2024-12-31.xsd#redcarepharmacynv_AcquisitionOfSubsidiaryWithNCI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_redcarepharmacynv_AcquisitionOfSubsidiaryWithNCI" xlink:to="lab_redcarepharmacynv_AcquisitionOfSubsidiaryWithNCI" xlink:type="arc" order="1"/>
    <link:label id="lab_redcarepharmacynv_IssuedCapitalAndSharePremium_label_en" xlink:label="lab_redcarepharmacynv_IssuedCapitalAndSharePremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en">Issued Capital and share premium</link:label>
    <link:label id="lab_redcarepharmacynv_IssuedCapitalAndSharePremium_documentation_en" xlink:label="lab_redcarepharmacynv_IssuedCapitalAndSharePremium" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en">Issued Capital and share premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_redcarepharmacynv_IssuedCapitalAndSharePremium" xlink:href="redcarepharmacynv-2024-12-31.xsd#redcarepharmacynv_IssuedCapitalAndSharePremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_redcarepharmacynv_IssuedCapitalAndSharePremium" xlink:to="lab_redcarepharmacynv_IssuedCapitalAndSharePremium" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_39f78df9-c5a3-4906-acbb-a7e3da33628b_negatedLabel_en" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en">Income taxes paid (refund), classified as operating activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:to="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_redcarepharmacynv_ChangesInCashAndCashEquivalents_label_en" xlink:label="lab_redcarepharmacynv_ChangesInCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en">Changes in cash and cash equivalents [Abstract]</link:label>
    <link:label id="lab_redcarepharmacynv_ChangesInCashAndCashEquivalents_documentation_en" xlink:label="lab_redcarepharmacynv_ChangesInCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en">Changes in cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_redcarepharmacynv_ChangesInCashAndCashEquivalents" xlink:href="redcarepharmacynv-2024-12-31.xsd#redcarepharmacynv_ChangesInCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_redcarepharmacynv_ChangesInCashAndCashEquivalents" xlink:to="lab_redcarepharmacynv_ChangesInCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_22f1ea93-189a-46c3-a373-b7818d07934f_totalLabel_en" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en">Increase (decrease) in cash and cash equivalents before effect of exchange rate changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
